We are live on
!
Find out more
PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$3.38B
1-Year Est. Return
14.09%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
+14.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.6B
AUM Growth
+$670M
(+23%)
Cap. Flow
+$559M
Cap. Flow
% of AUM
15.51%
Top 10 Holdings %
Top 10 Hldgs %
16.11%
Holding
2,193
New
624
Increased
517
Reduced
333
Closed
712
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$50.1M |
| 2 |
Union Pacific
UNP
|
+$23.2M |
| 3 |
Booking.com
BKNG
|
+$20.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$20.6M |
| 5 |
Boston Scientific
BSX
|
+$20M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$124M |
| 2 |
Cigna
CI
|
+$26.3M |
| 3 |
Lowe's Companies
LOW
|
+$26M |
| 4 |
Visa
V
|
+$24.5M |
| 5 |
UnitedHealth
UNH
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.68% |
| 2 | Healthcare | 7.32% |
| 3 | Consumer Discretionary | 7.26% |
| 4 | Financials | 6.68% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Codexis
CDXS
$175M
| $22K | ﹤0.01% |
7,844
+2,330
| +42% | +$7.54K |
|
|
GES
1377
DELISTED
Guess Inc
GES
| $21.1K | ﹤0.01% |
1,087
-2,473
| -69% | -$47.6K |
|
1378
Hawkins
HWKN
$2.67B
| $21.1K | ﹤0.01% |
+442
| New | +$19.9K |
|
1379
CALL
VanEck Gold Miners ETF
GDX
$26.9B
| $21.1K | ﹤0.01% |
700
-22,600
| -97% | -$736K |
|
|
CHUY
1380
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $20.8K | ﹤0.01% |
509
-154
| -23% | -$5.73K |
|
|
K
1381
CALL
DELISTED
Kellanova
K
| $20.2K | ﹤0.01% |
320
-9,265
| -97% | -$591K |
|
|
SA
1382
Seabridge Gold
SA
$3.46B
| $19.1K | ﹤0.01% |
+1,588
| New | +$21.6K |
|
|
SBDS
1383
DELISTED
Solo Brands Inc
SBDS
| $18.5K | ﹤0.01% |
+82
| New | +$20.4K |
|
1384
UNIFI
UFI
$120M
| $18.4K | ﹤0.01% |
+2,284
| New | +$17.9K |
|
1385
Coca-Cola Consolidated
COKE
$12.7B
| $18.4K | ﹤0.01% |
290
-1,160
| -80% | -$71.7K |
|
1386
Carvana
CVNA
$81B
| $18.1K | ﹤0.01% |
+3,500
| New | +$9.71K |
|
1387
Senseonics Holdings Inc
SENS
$409M
| $17.5K | ﹤0.01% |
+1,148
| New | +$15.7K |
|
|
CTV
1388
DELISTED
Innovid Corp.
CTV
| $17.2K | ﹤0.01% |
+15,766
| New | +$16.4K |
|
|
OMIC
1389
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $16.2K | ﹤0.01% |
+652
| New | +$19.1K |
|
|
SOL
1390
DELISTED
Emeren Group
SOL
| $16.1K | ﹤0.01% |
+4,241
| New | +$16.5K |
|
1391
Brink's
BCO
$4.72B
| $16K | ﹤0.01% |
+236
| New | +$15.8K |
|
1392
Smith & Nephew
SNN
$12.6B
| $16K | ﹤0.01% |
+495
| New | +$15.3K |
|
|
AY
1393
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $15.8K | ﹤0.01% |
+673
| New | +$17.3K |
|
1394
Voyager Therapeutics
VYGR
$198M
| $15.3K | ﹤0.01% |
1,340
-4,058
| -75% | -$42K |
|
|
ATRI
1395
DELISTED
Atrion Corp
ATRI
| $15.3K | ﹤0.01% |
27
+7
| +35% | +$4.09K |
|
1396
VistaGen Therapeutics
VTGN
$11.8M
| $14.4K | ﹤0.01% |
+7,720
| New | +$27.1K |
|
|
AFMD
1397
DELISTED
Affimed
AFMD
| $14.3K | ﹤0.01% |
+2,394
| New | +$19.2K |
|
1398
Rigel Pharmaceuticals
RIGL
$762M
| $14.2K | ﹤0.01% |
1,103
-263
| -19% | -$3.56K |
|
1399
Robert Half
RHI
$4.48B
| $14.1K | ﹤0.01% |
+188
| New | +$13.4K |
|
1400
Pliant Therapeutics
PLRX
$66.9M
| $13.7K | ﹤0.01% |
758
-7,025
| -90% | -$166K |
|
Similar funds
CC
SS
GW
WMSA
GC
WP
BWM
DI
Point72 Middle East FZE's Q2 2023 Portfolio in Review
As of Q2 2023, Point72 Middle East FZE held 2,193 positions worth $3.6B, up 23% from $2.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Middle East FZE deployed $559M of net new capital in Q2 2023, opening 624 new positions and adding to 517 existing holdings. Its largest new stake was AbbVie: 129,855 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $21.6M trimmed.
- Point72 Middle East FZE's largest Q2 2023 buy was AbbVie: 129,855 shares worth $17.5M.
- Point72 Middle East FZE added most to iShares Russell 2000 ETF in Q2 2023, an estimated $50.1M increase.
- Point72 Middle East FZE's biggest Q2 2023 reduction was Honeywell, cutting an estimated $21.6M.
- Point72 Middle East FZE fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $124M.
- Point72 Middle East FZE's ten largest holdings make up 16% of its $3.6B portfolio in Q2 2023.
- Point72 Middle East FZE opened 624 new positions and closed 712 in Q2 2023.
- Point72 Middle East FZE's portfolio value rose 23% quarter-over-quarter to $3.6B.
Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.